4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Cut to $35.00 by Analysts at Royal Bank of Canada
4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price target reduced by Royal Bank of Canada from $39.00 to $35.00 in a research note released on Monday,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. A number of other equities analysts have also recently issued reports on the company. […]
4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price target reduced by Royal Bank of Canada from $39.00 to $35.00 in a research note released on Monday,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. A number of other equities analysts have also recently issued reports on the company. […]
